Gsa Capital Partners LLP Ovid Therapeutics Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 123,583 shares of OVID stock, worth $55,612. This represents 0.01% of its overall portfolio holdings.
Number of Shares
123,583
Previous 260,509
52.56%
Holding current value
$55,612
Previous $307,000
62.54%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$2.39 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.8 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.73 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$1.68 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.42 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $31.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...